These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11758224)

  • 1. [Human factor VIII expression in retrovirus vector-transduced bone marrow stromal cells].
    Guo X; Wang H; Chu H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):461-3. PubMed ID: 11758224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow stromal cells as targets for gene therapy of hemophilia A.
    Chuah MK; Brems H; Vanslembrouck V; Collen D; VandenDriessche T
    Hum Gene Ther; 1998 Feb; 9(3):353-65. PubMed ID: 9508053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648.
    Chiang GG; Rubin HL; Cherington V; Wang T; Sobolewski J; McGrath CA; Gaffney A; Emami S; Sarver N; Levine PH; Greenberger JS; Hurwitz DR
    Hum Gene Ther; 1999 Jan; 10(1):61-76. PubMed ID: 10022531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.
    Chuah MK; Van Damme A; Zwinnen H; Goovaerts I; Vanslembrouck V; Collen D; VandenDriessche T
    Hum Gene Ther; 2000 Mar; 11(5):729-38. PubMed ID: 10757352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level expression of human factor VIII in mammalian cells after retroviral-mediated gene transfer.
    Guo X; Wang H; Chu H; Wang X; Qu B; Li Z; Qi Z; Wang Z
    Chin Med J (Engl); 2001 Jul; 114(7):690-3. PubMed ID: 11780328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo transfection and expression of human coagulant factor VIII cDNA in mice].
    Kang WY; Wang HL; Wang H; Wang XF; Wang CZ; Fu QH; Ding QL; Wu WM; Fang Y; Wang ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):188-93. PubMed ID: 15157331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
    Van Damme A; Chuah MK; Dell'accio F; De Bari C; Luyten F; Collen D; VandenDriessche T
    Haemophilia; 2003 Jan; 9(1):94-103. PubMed ID: 12558785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.
    Chuah MK; VandenDriessche T; Morgan RA
    Hum Gene Ther; 1995 Nov; 6(11):1363-77. PubMed ID: 8573610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retroviral-mediated high efficient in vitro expression of human coagulation factor VIII].
    Guo X; Wang H; Chu H; Wang X; Qu B; Li Z; Qi Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):457-9. PubMed ID: 11877017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient production of human FVIII in hemophilic mice using lentiviral vectors.
    Kootstra NA; Matsumura R; Verma IM
    Mol Ther; 2003 May; 7(5 Pt 1):623-31. PubMed ID: 12718905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effective and stable in vitro expression of human coagulation factor VIII by retrovirus-based plasmid vector coupled with polyamidoamine dendrimer].
    Kang WY; Wang HL; Wang XF; Wang H; Wang CZ; Fu QH; Ding QL; Wu WM; Fang Y; Duan BH
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):464-6. PubMed ID: 14575588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
    Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
    Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells.
    Moayeri M; Ramezani A; Morgan RA; Hawley TS; Hawley RG
    Mol Ther; 2004 Nov; 10(5):892-902. PubMed ID: 15509507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of factor VIII transgenes bioengineered for improved expression in gene therapy of hemophilia A.
    Dooriss KL; Denning G; Gangadharan B; Javazon EH; McCarty DA; Spencer HT; Doering CB
    Hum Gene Ther; 2009 May; 20(5):465-78. PubMed ID: 19222367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of murine hemophilia A by hematopoietic stem cell gene therapy.
    Moayeri M; Hawley TS; Hawley RG
    Mol Ther; 2005 Dec; 12(6):1034-42. PubMed ID: 16226058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes.
    Andrews JL; Weaver L; Kaleko M; Connelly S
    Haemophilia; 1999 May; 5(3):160-8. PubMed ID: 10444282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice.
    Connelly S; Smith TA; Dhir G; Gardner JM; Mehaffey MG; Zaret KS; McClelland A; Kaleko M
    Hum Gene Ther; 1995 Feb; 6(2):185-93. PubMed ID: 7537539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustaining expression of B domain-deleted human factor VIII mediated by using lentiviral vectors in NOD/SCID mouse.
    Li YJ; Chen C; Zeng LY; Cao J; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):658-63. PubMed ID: 22739177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.
    Powell JS; Ragni MV; White GC; Lusher JM; Hillman-Wiseman C; Moon TE; Cole V; Ramanathan-Girish S; Roehl H; Sajjadi N; Jolly DJ; Hurst D
    Blood; 2003 Sep; 102(6):2038-45. PubMed ID: 12763932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.